Citations for
1EIF2B4, EIF4A1, EIF4G2
DAP5 associates with eIF2β and eIF4AI to promote Internal Ribosome Entry Site driven translation.
Liberman N, Gandin V, Svitkin YV, David M, Virgili G, Jaramillo M, Holcik M, Nagar B, Kimchi A, Sonenberg N.
Nucleic Acids Res 43(7):3764-75. doi: 10.1093/nar/gkv205. Epub 2015 Mar 16. 2015
2EIF2B1, EIF2B4, VWM3, VWM4
Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.
Wu Y, Pan Y, Du L, Wang J, Gu Q, Gao Z, Li J, Leng X, Qin J, Wu X, Jiang Y.
J Hum Genet 54(2):74-7. Epub 2009 Jan 16. 2009
3EIF2B4, VWM4
Vanishing white matter disease: the first reported chinese patient.
Wong SS, Luk DC, Wong VC, Scheper GC, van der Knaap MS.
J Child Neurol 23(6):710-4. doi: 10.1177/0883073808314154. 2008
4EIF2B4
An efficient mammalian cell-free translation system supplemented with translation factors.
Mikami S, Masutani M, Sonenberg N, Yokoyama S, Imataka H.
Protein Expr Purif 46(2):348-57. Epub 2005 Oct 25. 2006
5EIF2B4, VWM4
The spectrum of mutations for the diagnosis of vanishing white matter disease.
Scali O, Di Perri C, Federico A.
Neurol Sci 27(4):271-7. Review. 2006
6VWM1, VWM2, VWM3, VWM4, VWM5, EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A, Henneke M, Brockmann K, Goerg M, Hanefeld F, Kohlschutter A, Gartner J.
Hum Mutat 25(4):411. 2005
7EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
The life and death of oligodendrocytes in vanishing white matter disease.
Van Haren K, van der Voorn JP, Peterson DR, van der Knaap MS, Powers JM.
J Neuropathol Exp Neurol 63(6):618-30. 2004
8EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.
Richardson JP, Mohammad SS, Pavitt GD.
Mol Cell Biol 24(6):2352-63. 2004
9EIF2B4
Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B.
Kobayashi H, Borsheim E, Anthony TG, Traber DL, Badalamenti J, Kimball SR, Jefferson LS, Wolfe RR.
Am J Physiol Endocrinol Metab 284(3):E488-98. 2003
10EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein.
Williams DD, Price NT, Loughlin AJ, Proud CG.
J Biol Chem 276(27):24697-703. Epub 2001 Apr 25. 2001
11EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation.
Gomez E, Pavitt GD.
Mol Cell Biol 20(11):3965-76. 2000
12EIF2B4
eIF2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2. Sequence conservation between the alpha, beta and delta subunits of eIF2B from mammals and yeast.
Price NT, Mellor H, Craddock BL, Flowers KM, Kimball SR, Wilmer T, Jefferson LS, Proud CG.
Biochem J 318 ( Pt 2):637-43. 1996
13EIF2B4
The delta-subunit of murine guanine nucleotide exchange factor eIF-2B. Characterization of cDNAs predicts isoforms differing at the amino-terminal end.
Henderson RA, Krissansen GW, Yong RY, Leung E, Watson JD, Dholakia JN.
J Biol Chem 269(48):30517-23. 1994